Brimonidine Tartrate Solution/ Drops
Product Images NDC 68083-626

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 68083-626). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brimonidine-spl-10ml-carton (Brimonidine Spl 10ml Carton)

Packaging label for Brimonidine Tartrate Ophthalmic Solution 0.1%, an eye drop solution. The label shows the active ingredient concentration, manufacturer Gland Pharma Limited, and packaging size of 10 mL. It includes usage instructions indicating the product is for eye use only and is sterile. The label also lists inactive ingredients and storage temperature.*

FDA Label Image

Brimonidine-spl-10ml-label (Brimonidine Spl 10ml Label)

Label for Brimonidine Tartrate Ophthalmic Solution 0.1% in a 10 mL bottle by Gland Pharma Limited. The label includes dosing instructions, storage temperature, and manufacturing details from Hyderabad, India, along with a barcode and area for lot and expiration information.*

FDA Label Image

Brimonidine-spl-15ml-carton (Brimonidine Spl 15ml Carton)

Packaging label for Brimonidine Tartrate Ophthalmic Solution 0.1%, 15 mL sterile drops by Gland Pharma Limited. The label states Rx only, the volume, and product NDC 68083-626-15. Active and inactive ingredients are listed, storage instructions (15° to 25°C), and a dosing note for eye use only are present. The manufacturer's information and barcode appear on one panel.*

FDA Label Image

Brimonidine-spl-15ml-label (Brimonidine Spl 15ml Label)

Brimonidine Tartrate Ophthalmic Solution 0.1% in a 15 mL bottle label. The label includes the active ingredient concentration, preservative information, dosage instructions, storage conditions, and manufacturer details from Gland Pharma Limited, Hyderabad, India. The label also features an eye graphic and indicates the product is sterile and for eye use only.*

FDA Label Image

Brimonidine-spl-5ml-carton (Brimonidine Spl 5ml Carton)

Carton label for Brimonidine Tartrate Ophthalmic Solution 0.1%, 5 mL, by Gland Pharma Limited. The label includes active and inactive ingredients, storage instructions, and a barcode. It is indicated for eye use only and marked as Rx only. The design shows the product name prominently with an eye graphic and dosage strength.*

FDA Label Image

Brimonidine-spl-5ml-label (Brimonidine Spl 5ml Label)

Label for Brimonidine Tartrate Ophthalmic Solution 0.1%, a 5 mL sterile eye drop solution by Gland Pharma Limited. Label includes NDC 68083-626-05, storage instructions at 15° to 25°C, usual dosage of one drop three times daily, and a barcode. Manufactured in Hyderabad, India.*

FDA Label Image

Brimonidine-spl-logo (Brimonidine Spl Logo)

FDA Label Image

Brimonidine-spl-structure (Brimonidine Spl Structure)

Chemical structure of Brimonidine Tartrate, depicting its molecular composition with functional groups including a brominated quinoxaline derivative linked to a tartrate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.